Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Myelodysplasia Transplantation-Associated Outcomes (MDS-TAO) Study

NCT02390414 is registered in ClinicalTrials.gov with Dana-Farber Cancer Institute as lead sponsor.

NCT NCT02390414
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02390414 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Myelodysplasia Transplantation-Associated Outcomes (MDS-TAO) Study
Lead sponsor
Dana-Farber Cancer Institute
Phase
Observational
Overall status
Completed
Start date
May 31, 2011
Completion date
September 30, 2020
Enrollment
290 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

myelodysplastic syndromes (mds)